Navigation Links
Congress Approves ePrescribing Initiative in Medicare Reform Bill: Critical Catalyst in Driving a New Generation of Prescribing
Date:7/11/2008

FRANKLIN LAKES, N.J., July 11 /PRNewswire-FirstCall/ -- In approving a Medicare reform bill that provides incentives for doctors to forego traditional pad-and-paper prescribing in favor of digital systems, Congress took the lead in protecting America's seniors and reached a major milestone in wiring the health care system, Medco Health Solutions (NYSE: MHS) said today.

"History shows that where Medicare goes, the rest of the health care system will surely follow," said David B. Snow Jr., Medco chairman and CEO. "By providing incentives for doctors to embrace ePrescribing technologies in prescriptions written for Medicare, Congress has created a catalyst for a long overdue transformation -- adoption of a system proven to reduce errors and improve efficiencies in the most frequently used process in modern health care: prescribing medicines."

Snow added: "ePrescribing efficiencies reduce the cost of processing a prescription, and can help save billions of dollars for Medicare, reducing paperwork for physicians and pharmacists, and safeguarding the health of America's seniors."

The ePrescribing initiative, which first provides financial incentives for doctors who submit prescriptions digitally and then -- following a transition period -- penalizes those who do not, was contained in broad-based Medicare legislation approved by both houses of Congress and forwarded to the President.

Medco played an instrumental role in a broad coalition of pharmacy industry groups, insurers, employers, clinicians, and patient-advocacy organizations in supporting efforts to incent the adoption of secure digital prescribing technologies to improve clinical outcomes for patients and financial outcomes for payors.

"In particular, we commend five members of Congress who showed the foresight and leadership to spearhead this initiative: Senate Finance Committee members John Kerry (D-Mass.) and John Ensign (R-Nev.) and House of Representatives members Allyson Schwartz (D-Penn.), Jon Porter (R-Nev.) and Lois Capps (D-Calif.)," Snow said.

Although surveys reveal that 90 percent of physicians support ePrescribing, fewer than 1 in 10 currently use the life-saving technology.

Medco, in one of the largest ePrescribing pilots in America and in collaboration with several partners in Southeast Michigan, revealed that:

-- Nearly 65 percent of physicians reported changing a prescription due to safety alerts transmitted through the system.

-- 75 percent of physicians said the technology improved safety for their patients.

-- Approximately 70 percent were very satisfied with the ease of identifying drug-to-allergy and drug-to-drug interactions.

It is estimated that over the next 10 years, up to 80 percent of prescriptions will be transmitted electronically.

"Medicare has traditionally served as a critical tipping point for the broad adoption of new medical practices," said Snow. "As doctors begin using these technologies for their Medicare patients, they will, predictably, use those technologies across their entire patient populations."

About Medco

Medco Health Solutions, Inc., (NYSE: MHS) is the nation's leading pharmacy benefit manager based on its 2007 total net revenues of more than $44 billion. Medco's prescription drug benefit programs, covering approximately one-in-five Americans, are designed to drive down the cost of pharmacy health care for private and public employers, health plans, labor unions and government agencies of all sizes, and for individuals served by the Medicare Part D Prescription Drug Program and those served by its specialty pharmacy segment, Accredo Health Group. Medco, the world's most advanced pharmacy(TM), is positioned to serve the unique needs of patients with chronic and complex conditions through its Medco Therapeutic Resource Centers(R), including its enhanced diabetes pharmacy care practice through the Liberty acquisition. Medco is the highest-ranked independent pharmacy benefit manager on the 2008 Fortune 100 list. On the Net: http://www.medco.com.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward- looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.


'/>"/>
SOURCE Medco Health Solutions, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. American Life League Applauds Congressional Action Against Planned Parenthood
2. Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary
3. FTC Acts to Prevent Tobacco Industry Deception About Tar, Nicotine Levels; Congress Should Go Further by Giving FDA Authority Over Tobacco Products
4. Congress Called on to Hold Dental Mercury Polluters Accountable at U.S. House Oversight Hearing
5. 21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain
6. Minnesota Nurses Association Endorses Ashwin Madia for Congress
7. Minnesota Nurses Association Endorses Steve Sarvi for Congress
8. Minnesota Nurses Association Endorses Elwyn Tinklenberg for Congress
9. Proposed Congressional Legislation Would Cut $358 Million From the Medicare Advantage Program in Texas
10. Proposed Congressional Legislation Would Cut $143 Million from the Medicare Advantage Program in Georgia
11. Proposed Congressional Legislation Would Cut $222 Million from the Medicare Advantage Program in Massachusetts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... , ... The Anaheim Hills office accelerates and supports FNCC’s growth and further ... sales professionals over the past 6 months and is continuing to recruit new talent ... course of 2017. , “This new office is a direct result of our ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... with opioids alone responsible for over 33,000 of the 52,404 drug-related deaths in ... Bill (AB) 1512, which proposes a tax on prescription opioids to fund drug ...
(Date:3/25/2017)... ... ... Swissray is pleased to announce the release of the ELITE DXA, a new bone ... scan window, which is more than double that of existing bone densitometers. Historically, subjects ... an accurate total body bone density or body composition study. The ELITE DXA ...
(Date:3/24/2017)... ... March 24, 2017 , ... Digital Scientists, a software innovation lab specializing in ... a Greenville, South Carolina location. The lab has set up shop at ... been working with South Carolina clients for years from our office here in Atlanta,” ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... related services to families and business owners across eastern Michigan, is connecting with ... families struggling with financial difficulties. , The Oxford/Orion FISH Food Pantry works to ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... March 27, 2017  A recent study at Shriners ... freestanding hospitals in the country dedicated to the treatment ... surgery, concluded that the Surfacide Helios ® UV-C ... in reducing bacterial pathogens not killed by the EVS ... at the American Burn Association,s 49th Annual Meeting in ...
(Date:3/27/2017)... , March 27, 2017 ... 7,000 attendees and more than 600 exhibitors from ... discover opportunities and solutions that will advance the ... April 2017 at the Messe Stuttgart, ... preeminent medical technology platform showcasing the key trends ...
(Date:3/27/2017)... March 27, 2017  Sophiris Bio Inc. (NASDAQ: ... a clinical late-stage biopharmaceutical company developing topsalysin (PRX302) ... today reported fourth quarter and full year 2016 ... Key Corporate Highlights: Advanced ... Cancer. During 2016, the Company reported successful results ...
Breaking Medicine Technology: